Skip to main content

Dyne Therapeutics, Inc.

DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818794

In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Dyne Therapeutics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of DYN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders118114−4
Shares59.2M59.9M+699.0K (+1.2%)
Value$665.9M$536.6M−$129.3M (−19.4%)

New holders (10)

Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to DYN in Q3 2023
InstitutionSharesValue% of portfolio
Walleye Capital LLC280,276$2.51M0.04%
Group One Trading, L.P.60,334$540.6K0.02%
Jane Street Group, LLC51,221$458.9K0.00%
Simplex Trading, LLC36,032$322.0K0.01%
Walleye Trading LLC24,326$218.0K0.01%
TD Asset Management Inc23,000$206.1K0.00%
Balyasny Asset Management LLC17,646$158.1K0.00%
Belvedere Trading LLC16,058$143.9K0.02%
Quarry LP3,200$28.7K0.02%
Comerica Bank175$1.57K0.00%

Sold out (14)

Institutions that held Dyne Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of DYN in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
EcoR1 Capital, LLC798,701$8.99M
Polar Capital Holdings Plc500,000$5.63M
Norges Bank195,600$2.20M
Sphera Funds Management Ltd.119,918$1.35M
Adage Capital Partners GP, L.L.C.100,000$1.13M
Federated Hermes, Inc.82,400$927.0K
Integral Health Asset Management, LLC62,000$697.5K
Public Employees Retirement System of Ohio39,796$448.0K
Squarepoint Ops LLC34,063$383.2K
Trexquant Investment LP27,380$308.0K
Jacobs Levy Equity Management, Inc24,279$273.1K
Ameriprise Financial Inc13,300$149.6K
Denali Advisors LLC2,700$30.4K
CWM, LLC43$0